Variable | Category | Total (%) | AHD N=57 (16%) | LP N=61 (17%) | NLP N=238 (67%) | p Value (2 sided) |
---|---|---|---|---|---|---|
Gender | 0.003 | |||||
Male | 300 (84) | 41 (13.6%) | 51 (17%) | 208 (69.3%) | ||
Female | 56 (16) | 16 (28.6%) | 10 (17.8%) | 30 (53.6%) | ||
Transmission mode | <0.0001 | |||||
MSM | 217 (61) | 24 (11%) | 39 (18) | 154 (71) | ||
Heterosexuals | 87 (24.4) | 28 (32.2) | 17 (19.5%) | 42 (48.3%) | ||
IVDU | 52 (14.6) | 5 (9.6%) | 5 (9.6%) | 42 (80.8%) | ||
Place of birth | 0.03 | |||||
Israel | 246 (69.5) | 32 (13%) | 40 (16.3%) | 174 (70.7%) | ||
East Europe | 92 (26) | 19 (20.6%) | 19 (20.6%) | 54 (58.8%) | ||
Ethiopia | 16 (4.5) | 6 (37.5%) | 2 (12.5%) | 8 (50%) | ||
Other | 0 | 0 | 2 (0.8%) | |||
Median age at diagnosis | 40.2 | 36.8 | 34.4 | 0.0003 | ||
Age >50 years | 12 (21%) | 11 (18%) | 19 (8%) | 0.0002 |
AHD, advanced HIV disease; IVDU, intravenous drug user;
LP, late presenters; MSM, men who have sex with men;
NLP, not late presenters.